| 日付 |
時間 |
ソース |
タイトル |
|---|
| 2024/4/20 | 05:05 | EDGAR2 | Form ARS - Annual Report to Security Holders |
| 2024/4/20 | 05:04 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
| 2024/4/20 | 05:02 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
| 2024/3/20 | 06:10 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
| 2024/3/20 | 06:02 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 2024/3/19 | 20:09 | EDGAR2 | Form 8-K - Current report |
| 2023/11/21 | 08:15 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/11/21 | 08:14 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/11/07 | 06:30 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
| 2023/10/31 | 05:15 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
| 2023/10/28 | 06:17 | EDGAR2 | Form 8-K - Current report |
| 2023/10/28 | 05:02 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
| 2023/10/27 | 06:34 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/10/27 | 06:00 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/10/27 | 05:46 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/10/21 | 10:23 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
| 2023/10/18 | 06:47 | GLOBE | Talaris Therapeutics Announces Stockholder Approval of.. |
| 2023/10/11 | 05:32 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 2023/10/11 | 05:30 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
| 2023/10/07 | 09:01 | DJN | Stocks to Watch: Shift Technologies, Talaris Therapeutics,.. |
| 2023/10/07 | 06:30 | EDGAR2 | Form 8-K - Current report |
| 2023/10/07 | 06:27 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 2023/10/07 | 06:26 | EDGAR2 | Form 8-K - Current report |
| 2023/10/07 | 06:09 | GLOBE | Talaris Therapeutics Declares Special Dividend In Connection.. |
| 2023/10/04 | 21:30 | GLOBE | New York Blood Center Enterprises Acquires Commercial-Scale.. |
| 2023/9/26 | 21:24 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 2023/9/26 | 21:21 | EDGAR2 | Form 8-K - Current report |
| 2023/9/15 | 19:31 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 2023/9/14 | 05:28 | EDGAR2 | Form S-4/A - Registration of securities, business.. |
| 2023/9/13 | 22:14 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 2023/9/13 | 22:13 | EDGAR2 | Form 8-K - Current report |
| 2023/9/12 | 05:47 | EDGAR2 | Form S-4/A - Registration of securities, business.. |
| 2023/8/28 | 20:38 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 2023/8/26 | 05:34 | EDGAR2 | Form S-4/A - Registration of securities, business.. |
| 2023/8/14 | 20:53 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 2023/6/22 | 20:30 | GLOBE | Talaris Therapeutics and Tourmaline Bio Announce Merger.. |
| 2023/5/26 | 20:00 | GLOBE | Talaris Therapeutics Announces Leadership Transition |
Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
